These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Photodynamic therapy--a conservative alternative in treatment of exudative macular degeneration]. Schmidt-Erfurth U Klin Monbl Augenheilkd; 1998 Dec; 213(6):aA11-5. PubMed ID: 10048006 [No Abstract] [Full Text] [Related]
9. NICE recommends photodynamic therapy for certain patients with macular degeneration. Mayor S BMJ; 2003 Sep; 327(7417):698. PubMed ID: 14512456 [No Abstract] [Full Text] [Related]
11. Effects of photodynamic therapy on subfoveal blood flow in neovascular age-related macular degeneration patients. Vinh Moreau-Gaudry V; Geiser M; Romanet JP; Hera R; Millet JY; Chiquet C Eye (Lond); 2010 Apr; 24(4):706-12. PubMed ID: 19543242 [TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy in the anti-VEGF era. Fine HF Br J Ophthalmol; 2007 Jun; 91(6):707-8. PubMed ID: 17510474 [TBL] [Abstract][Full Text] [Related]
13. Approaches toward combining photodynamic therapy with pharmaceuticals that alter vascular microenvironment. Busch T Retina; 2009 Jun; 29(6 Suppl):S36-8. PubMed ID: 19553798 [TBL] [Abstract][Full Text] [Related]
14. Estimating the potential impact of using intravitreal angiostatic agents for wet macular degeneration on service capacity in a large retinal referral centre. Cheung CM; Peh KK; Yang Y Eye (Lond); 2007 Aug; 21(8):1121-2. PubMed ID: 17525768 [No Abstract] [Full Text] [Related]
15. Combined ranibizumab and photodynamic therapy to treat exudative age-related macular degeneration: an option for improving treatment efficiency. Mataix J; Palacios E; Carmen DM; Garcia-Pous M; Navea A Retina; 2010 Sep; 30(8):1190-6. PubMed ID: 20539256 [TBL] [Abstract][Full Text] [Related]
16. [Future methods of treatment in age related macular degeneration]. Turlea C Oftalmologia; 2012; 56(1):30-5. PubMed ID: 22888684 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of choroidal neovascularisations with photodynamic therapy]. Lang GE Klin Monbl Augenheilkd; 2003 Oct; 220(10):653. PubMed ID: 14577031 [No Abstract] [Full Text] [Related]
18. [Photodynamic therapy for age-related macular degeneration in Japanese patients]. Iida T Nippon Ganka Gakkai Zasshi; 2008 Oct; 112(10):843-5. PubMed ID: 18949908 [No Abstract] [Full Text] [Related]
19. Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study. Sadda SR; Stoller G; Boyer DS; Blodi BA; Shapiro H; Ianchulev T Retina; 2010 Oct; 30(9):1390-9. PubMed ID: 20924261 [TBL] [Abstract][Full Text] [Related]
20. Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. Curtis LH; Hammill BG; Schulman KA; Cousins SW Arch Ophthalmol; 2010 Oct; 128(10):1273-9. PubMed ID: 20937996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]